REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
09/27/2025
Back to search
Official data from USPTO
SHEFFIELD PHARMACEUTICALS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
SHEFFIELD PHARMACEUTICALS
ST13
US500000086724022Class
40
Filing
86724022
Registration
5048004
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
27
Latest update
09/28/2025
Trademark type
Word
Nice classes
40
Filing date
08/13/2015
Registration date
09/27/2016
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/29/2023
Last transaction
09/28/2025
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
First use anywhere
02/28/2005
First use in commerce
02/28/2005
Drawing code
4
Owner type
16
Owner location
New London, CT
Examiner
FALK,JONATHAN ROBERT
Law office
M20
Current location
TMO LAW OFFICE 111
Holders and representatives
Holders
Sheffield Pharmaceuticals, LLC
Representatives
Peter J. Davis Whiteford, Taylor & Preston, LLP
Technical classification
Nice Classes
Class 40
Vienna Codes
No Vienna codes available.
Goods and services
Class 40
Contract manufacturing in the field of medicated and non-medicated preparationspharmaceutical preparations for the treatment of dental cariessensitivityoral care for pain and irritationnasal congestion and moisturizingnon-prescription medications for topical application for the treatment of skin irritations such as psoriasis and seborrheic dermatitiseczemaacneitching associated with poison ivypoison oaksumacexternal feminine and genital irritationminor aches and pains associated with arthritisrelief of discomfort caused by hemorrhoidsanorectal disordersfirst aid to prevent infectionskin care preparations used to treat and prevent diaper rash and chafed skinathlete's foot and jock itchnon-medicated preparations for use as a personal lubricantdenture relinerdenture adhesive creamwound carecosmetic skin care preparationsskin moisturizeranti-wrinkle creameye serum and facial cleanser and cosmetic teeth whitener and dentifricehomeopathic pharmaceuticals for use in the treatment of ear ache and nasal decongestionpain relief medicationspreparations for the relief of painoral analgesic preparationsoral anesthetic preparationsskin creamsointmentsgelsanti-aging preparationscreamsnon-medicated hair treatment preparations for cosmetic purposesnon-medicated hair removal preparations; manufacturing of private label and branded preparationspharmaceutical preparations for the treatment of dental cariessensitivityoral care for pain and irritationnasal congestion and moisturizingnon-prescription medications for topical application for the treatment of skin irritations such as psoriasis and seborrheic dermatitiseczemaacneitching associated with poison ivypoison oaksumacexternal feminine and genital irritationminor aches and pains associated with arthritisrelief of discomfort caused by hemorrhoidsanorectal disordersfirst aid to prevent infectionskin care preparations used to treat and prevent diaper rash and chafed skinathlete's foot and jock itchnon-medicated preparations for use as a personal lubricantdenture relinerdenture adhesive creamwound careanti-aging preparationscreamsnon-medicated hair treatment preparations for cosmetic purposesnon-medicated hair removal preparations
Publications
History of USPTO decisions and trademark events.
27 publications found
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
03/29/2023
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
03/29/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
03/29/2023
E815
TEAS SECTION 8 & 15 RECEIVED
09/19/2022
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
09/27/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
09/27/2016
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/12/2016
PUBO
PUBLISHED FOR OPPOSITION
07/12/2016
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/22/2016
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06/16/2016
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06/16/2016
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
06/15/2016
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/02/2016
XAEC
EXAMINER'S AMENDMENT ENTERED
06/02/2016
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
06/02/2016
GNEA
EXAMINERS AMENDMENT E-MAILED
06/02/2016
CNEA
EXAMINERS AMENDMENT -WRITTEN
06/02/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/12/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/11/2016
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/11/2016
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
11/19/2015
GNRT
NON-FINAL ACTION E-MAILED
11/19/2015
CNRT
NON-FINAL ACTION WRITTEN
11/19/2015
DOCK
ASSIGNED TO EXAMINER
11/17/2015
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/18/2015
NWAP
NEW APPLICATION ENTERED
08/17/2015
Continuous trademark protection
Get notified about every new filing that threatens SHEFFIELD PHARMACEUTICALS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.